08.06.2012
- Danish drugmaker Novo Nordisk , the world's biggest insulin maker, said on Friday that U.S. health regulators had extended their review of its new ultra-long-acting insulin Tresiba...
31.05.2012
- We are delighted to present you with this supplement for the ACHEMA 2012. On the next eight pages, we invite you to discover a one-of-a-kind reference, our leading resource, the...
25.05.2012
- The owners of Evonik Industries, RAG-Stiftung (74.99%) and CVC Funds (25.01%), together with Evonik's Supervisory Board and Executive Board, confirm that they plan to list the...
07.05.2012
- Swiss drugmaker Roche has ended efforts to develop a heart disease drug which some industry analysts had estimated could have achieved $10 billion in annual sales, after poor...
28.04.2012
- French drugmaker Sanofi posted better-than-expected quarterly results, bolstered by strong emerging markets, breaking with a trend of earnings misses by European rivals AstraZeneca...
27.04.2012
- Danish drugmaker Novo Nordisk said it expected its U.S. insulin market share to improve and edged up its full-year targets after stiff competition for insulin and disappointing...
27.04.2012
- Pharmaceutical firm Shire posted a 20% rise in first-quarter earnings on Thursday, just beating market expectations, as its drugs to treat hyperactivity again lifted market share...
25.04.2012
- German industrial conglomerate Evonik may put its planned second-quarter listing on ice if valuations in the chemical sector remain at current levels, two sources close to the...
24.04.2012
- Watson Pharmaceuticals aims to announce an agreement to buy Actavis for around $6 billion on Wednesday, April 25th, in a deal making it one of the world's biggest suppliers of...
20.04.2012
- European regulators have endorsed the continued use of Novartis's multiple sclerosis pill Gilenya, one of the Swiss firm's top new drug hopes, but said on Friday the drug needed to...
